QuickRing

Company Overview

Snapshot

Founded in October 2010, QuickRing operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the development of its patented technology for sutureless heart valve repair.

Business overview

QuickRing is a Health Tech & Life Sciences company developing a technology for sutureless heart valve repair procedures. Its core product is a patented system that utilizes a proprietary stapler and smart staples to secure an annuloplasty ring, eliminating the need for sutures. The company is primarily focused on sutureless mitral valve annuloplasty repair, serving the medical devices industry and healthcare providers with innovations addressing challenges faced by cardiac surgeons and enabling next-generation patient care, including minimally invasive and robotic approaches.

Company Intelligence Q&A

What is QuickRing's primary focus?

QuickRing is primarily focused on developing a technology for sutureless heart valve repair procedures, specifically sutureless mitral valve annuloplasty repair.

What technology does QuickRing utilize for heart valve repair?

QuickRing utilizes a patented system that includes a proprietary stapler and smart staples to secure an annuloplasty ring in place, replacing traditional sutures.

When was QuickRing founded?

QuickRing was founded in October 2010.

What problem does QuickRing's technology aim to solve?

QuickRing's technology aims to address present-day challenges for cardiac surgeons by enabling sutureless heart valve repair, facilitating minimally invasive approaches and fully robotic support for patient care.

What is QuickRing's current product development stage?

QuickRing is currently in the R&D stage for its patented system.